Telenor ASA (TEL)
Verdict history · TEL
Every call Verdix has made on TEL.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior WAIT hinged on either a monthly close above the EMA20 or stabilisation in the 125–130 zone with a bullish MACD crossover. Neither materialised. Instead, price drifted lower within a widening bearish MACD and the fundamental picture worsened with near-term EPS estimates cut 24%, tilting the balance from “value is present but wait for confirmation” to “the path of least resistance is down until the weekly EMA200 at 138.57 is reclaimed.”
See methodology for how verdicts are produced. Full track record →
The panel’s case against TEL — and where they disagree.
The case against outweighs the case for at today's price.
OSL · Communication Services · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
A panel of six archetypes turns bearish on Telenor after technical deterioration and a July guidance cut overwhelm an otherwise attractive 10.2% FCF yield: all four bearish voices see a confirmed Stage 4 decline with earnings still sliding, while two neutrals acknowledge the value but refuse to step in front of the downtrend until the weekly EMA200 at 138.57 is reclaimed.Level to watch
Key resistance 138.57+3.3% from 134.1
Next catalyst
Trigger to flip bullish: A weekly close above the EMA200 at 138.57 would break the Stage 4 bear cascade and is the single most important technical condition all four bearish voices cite as necessary to reconsider.The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: 134.1 · Changed from WAIT
Panel: 0 Bullish · 2 Neutral · 4 Bearish → SELL
What changed since 2026-08-15:
- Price: 134.6 → 134.1 (-0.37%)
- Panel: 0 of 6 → 0 of 6 still Bullish, unchanged — same 6 of 6 split
- Trigger: A weekly close above the EMA200 at 138.57 would break the Stage 4 bear cascade and flip this to a BUY. A breakdown below the weekly POC at 129.35 would confirm acceleration toward 125.20 and the monthly 61.8% Fib at 122.40.
- Verdict: WAIT → SELL
The prior WAIT hinged on either a monthly close above the EMA20 or stabilisation in the 125–130 zone with a bullish MACD crossover. Neither materialised. Instead, price drifted lower within a widening bearish MACD and the fundamental picture worsened with near-term EPS estimates cut 24%, tilting the balance from “value is present but wait for confirmation” to “the path of least resistance is down until the weekly EMA200 at 138.57 is reclaimed.”
The prior WAIT trigger required either a monthly close above EMA20 (~147.49) or stabilisation in the 125–130 zone with a bullish MACD crossover; neither has occurred — price fell from 134.6 to 134.1 and the MACD histogram is still widening negative. The bearish shift is driven by technical deterioration (unambiguous weekly Stage 4, monthly approaching a death cross) and fundamental erosion (Q2 guidance cut, -24% near-term EPS revisions, zero insider buying), which now outweigh the attractive forward P/E and FCF yield that kept the prior call at WAIT. The two neutral voices — The Moat Compounder and The Intrinsic-Value Modeler — both acknowledge the value but refuse to step in front of a confirmed downtrend; all four bearish voices are unanimous that the path of least resistance is down until the weekly EMA200 at 138.57 is reclaimed.
Key levels
Key levels · TEL
NOK · as of 2026-08-22Analyst consensus target 174.1 NOK · range 139.38–220.5
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance begins at the weekly EMA200 at 138.57 — the first structural overhead hurdle that, if reclaimed, would break the Stage 4 bear cascade; the stock has not closed above it since the decline began. Above that, the monthly 38.2% Fib at 143.90 and the monthly EMA20 at ~147.44 form a thicker resistance band. Key support sits at 129.35, the weekly volume profile POC and the highest-volume liquidity node on that timeframe — it is the next magnet if the current 133.15 monthly 50% Fib gives way. The analyst consensus target of 174.10 sits 30% above price, reflecting stale estimates that have not fully repriced the July guidance cut.
What legendary investors think
We ran Telenor ASA past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: TTM free cash flow of 18.1B NOK runs at a 10.2% FCF yield at the current price, anchoring intrinsic value around 145 NOK even under a flat-then-2% growth assumption. Conviction: Conviction is capped at 55% because the DCF swings 15–20 NOK per share for each 1% change in terminal growth or WACC, and the technical backdrop remains a Stage 4 decline that the model does not incorporate.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The consensus mean target of 174.1 NOK has not caught up to the July guidance cut, and near-term EPS estimates have already been slashed 24% in one month, confirming that the earnings-revision trend still points down. Conviction: Confidence rises to 65% because three independent facts align: unambiguous weekly Stage 4 price action, a history of negative earnings surprises averaging -18.85%, and zero insider buying after a 25% drawdown.
The Moat CompounderValue/Quality/Moat⚫ NeutralLow
Signal: Owner earnings of roughly 13.5 NOK per share generate a 10.1% FCF yield, which offers a margin of safety for a fair business, but the moat is narrow and the capital intensity means significant reinvestment is required just to defend existing earnings power. Conviction: The neutral stance persists because the business is not wonderful enough to override the absence of a technical bottom; a wider margin of safety would require a pullback toward 120–125 before enthusiasm can build.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: A forward P/E of 13.3x and a PEG of 1.24 look cheap, but the Q2 guidance cut to flat EBITDA signals the core Nordic business is softening and earnings are still being revised lower, which is the opposite of the reacceleration a stalwart-to-recovery play demands. Conviction: Conviction is held back only by the 10.2% FCF yield as a counterargument; without it, the combination of a textbook Stage 4 decline, absent insider buying, and deteriorating fundamentals would push confidence much higher.
The Asymmetric BargainerContrarian/Deep Value🔴 BearishMed
Signal: The Dhandho checklist fails on the first question about limited downside because price sits below the weekly EMA200 at 138.57 with only the monthly 50% Fib at 133.15 standing between current levels and the 129.35 volume POC, leaving 15–20% of additional downside before structural support. Conviction: The expected-value math keeps conviction at 60% because a 35% chance of losing 20% versus a 45% chance of gaining 10% produces a weighted outcome barely above breakeven, and an asymmetric bet requires the odds to lean heavily in one direction.
The Quality RationalistMental Models/Quality🔴 BearishMed
Signal: Reported trailing return on investment sits at just 5.12%, well below any reasonable cost of capital for a leveraged telecom, meaning the business consumes 37% of operating cash flow in capex simply to stand still rather than compound. Conviction: Confidence reaches 70% because the bearish case rests on multiple hard-to-dispute facts: a confirmed Stage 4 price structure, a guidance cut delivered by management themselves, an Altman Z-Score of 1.93 in the grey zone, and virtually no insider buying after the stock collapsed.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six archetypes agree that free cash flow is genuine and substantial, with the 10.2% FCF yield representing the single strongest fundamental anchor for the stock.
- Every archetype, including the two neutrals, acknowledges that the technical picture is unambiguously bearish: Stage 4 weekly decline, price below all EMAs, and widening negative MACD.
- All six voices flag the absence of insider buying after a 25% drawdown from the 52-week high as a meaningful negative signal.
- There is unanimous recognition that the July 2026 guidance cut is a genuine fundamental deterioration, not a one-time accounting noise, and that near-term EPS revisions are still trending down.
The real debate
- The Intrinsic-Value Modeler and The Moat Compounder both see enough value to stay neutral, arguing the FCF yield provides a floor and the guidance cut is a transitional headwind rather than a structural break, while The Quality Rationalist and The GARP Operator counter that cheapness alone is not a catalyst when earnings are still being revised down and the moat is too narrow to justify stepping in front of a confirmed downtrend.
- The Forensic Skeptic sees the consensus analyst target as stale and likely to be revised further downward, while The Intrinsic-Value Modeler notes the same consensus range implies 30% upside and treats the wide dispersion as a sign of uncertainty rather than a setup for further cuts.
- The Asymmetric Bargainer frames the decision purely as a probability-weighted payoff problem and concludes the expected value is flat at best, whereas The Moat Compounder frames it as a business-quality question and would accept a bumpy wait if the margin of safety were wider.
The question it comes down to: Will the 10.2% FCF yield prove to be a durable floor that eventually attracts buyers once the technical decline exhausts itself, or is it a value trap where earnings continue to deteriorate faster than the multiple compresses?
The bottom line
- Trigger to flip bullish: A weekly close above the EMA200 at 138.57 would break the Stage 4 bear cascade and is the single most important technical condition all four bearish voices cite as necessary to reconsider.
- Critical support to monitor: A breakdown below the weekly volume POC at 129.35 would confirm acceleration toward the 125.20 level and the monthly 61.8% Fibonacci retracement at 122.40, removing the last structural floor before the low 110s.
- Next fundamental catalyst: Q3 2026 earnings in late October will test whether Nordic service revenue has stabilised and whether management revises or reaffirms the already-cut full-year guidance; another negative surprise would validate the -24% near-term EPS revision trend.
- Sentiment signal to watch: A material insider purchase by a board member or executive above 1M NOK would directly contradict the current absence of conviction buying and would independently force a reassessment of the downside case.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in TEL · TEL verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated